title: Vigabatrin causes profound reduction in serum alanine transaminase activity.
authors.affiliation: Dundee Teaching Hospitals NHS Trust, Ninewells, Scotland, UK.
authors.forename: M F
authors.initials: MF
authors.lastname: Ryan
authors.forename: A
authors.initials: A
authors.lastname: Samy
authors.forename: J
authors.initials: J
authors.lastname: Young
mesh_terms: D000410:Alanine Transaminase / Q000037:antagonists & inhibitors* / Q000097:blood; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D004791:Enzyme Inhibitors; D005680:gamma-Aminobutyric Acid; D000410:Alanine Transaminase; D020888:Vigabatrin